<p>Indicated for the treatment of premature ejaculation (PE) in men 18 to 64 years of age, who have all of the following:</p>

<ul>
	<li>Persistent or recurrent ejaculation with minimal sexual stimulation before, on or shortly after penetration and before the patient wishes.</li>
	<li>Marked personal distress or interpersonal difficulty as a consequence of PE and poor control over ejaculation.</li>
</ul>